MedTrace Logo

KM110329 in Adult Patients With Atopic Dermatitis

NCT01692093 · Status: UNKNOWN · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 66

Last updated 2013-11-14

No results posted yet for this study

Summary

The purpose of this study is to determine clinical efficacy and safety of KM110329 for Atopic dermatitis.

Conditions

Interventions

DIETARY_SUPPLEMENT

KM110329

KM110329, a functional food consist of four herbs which are shown to be beneficial for skin health

DIETARY_SUPPLEMENT

Placebo

Placebo

Sponsors & Collaborators

  • St Mary's Hospital, London

    collaborator OTHER

  • Chung-Ang University Hosptial, Chung-Ang University College of Medicine

    collaborator OTHER

  • Kyung Hee University Hospital at Gangdong

    collaborator OTHER

  • Kyunghee University Medical Center

    lead OTHER

Principal Investigators

  • SEONG GYU KO, M.D.(DKM) · Kyunghee University

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
TRIPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2012-09-30
Primary Completion
2014-06-30
Completion
2014-09-30

Countries

  • South Korea

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01692093 on ClinicalTrials.gov